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Characterization of a population of neural progenitor cells in the infant hippocampus
Aims: Abnormalities of the hippocampus are associated
with a range of diseases in children, including epilepsy and
sudden death. A population of rod cells in part of the
hippocampus, the polymorphic layer of the dentate gyrus,
has long been recognized in infants. Previous work sug-
gested that these cells were microglia and that their pres-
ence was associated with chronic illness and sudden infant
death syndrome. Prompted by the observations that a sen-
sitive immunohistochemical marker of microglia used in
diagnostic practice does not typically stain these cells and
that the hippocampus is a site of postnatal neurogenesis,
we hypothesized that this transient population of cells were
not microglia but neural progenitors. Methods: Using
archived post mortem tissue, we applied a broad panel of
antibodies to establish the immunophenotype of these cells
in 40 infants dying suddenly of causes that were either
explained or remained unexplained, following post mortem
investigation.Results:The rod cells were consistently nega-
tive for the microglial markers CD45, CD68 and HLA-DR.
The cells were positive, in varying proportions, for the
neural progenitor marker, doublecortin, the neural stem
cell marker, nestin and the neural marker, TUJ1. Conclu-
sions: These data support our hypothesis that the rod cells
of the polymorphic layer of the dentate gyrus in the infant
hippocampus are not microglia but a population of neural
progenitors. These findings advance our understanding of
postnatal neurogenesis in the human hippocampus in
health and disease and are of diagnostic importance,
allowing reactive microglia to be distinguished from the
normal population of neural progenitors.
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Introduction
Abnormalities of the hippocampus have been linked to a
range of pathological states in children, including epilepsy
[1] and sudden death [2,3]. Clusters of rod-shaped cells are
frequently seen at post mortem in infants in part of the
hippocampal complex, the polymorphic layer (PML) of the
dentate gyrus (DG). The PML is the inner layer of the three
that make up the DG and lies between the granule cells of
the DG and the pyramidal cells of CA4 [4]. On the basis
of morphology (including ultrastructure), lectin histo-
chemistry and immunohistochemistry for HAM56, it has
been reported that these rod cells in the PML of infants were
microglia [5].These cells were rarely seen beyond 9 months
of corrected age and were more frequent in infants dying of
a range of chronic hypoxic or hypotensive states and in
sudden infant death syndrome (SIDS) [5] than in infants
dying of acute causes.
The presence of these characteristic cells in the PML of
infants dying suddenly has since been interpreted as evi-
dence of hypoxic/ischaemic injury [6,7]. Furthermore,
the finding in the initial report that rod cells were not seen
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in the PML of infants dying less than 4 days after brain
injury [5] has been cited as evidence that this is the period
required for a microglial response to develop [8].
In the course of our diagnostic practice, we made two
observations: that the rod cells of the PML were not
identified by antibodies directed against CD68, a sensitive
marker of microglia routinely used in neuropathological
practice, and, consistent with the original report, that the
rod cells were only present in infants [5]. A reduction in
cellularity of the PML between birth and the age of 9
months has also been reported by an independent group
[4]. Given that the hippocampus is a site of postnatal
neurogenesis [9], we hypothesized that this transient
population of cells were not microglia but neural progeni-
tors. The aim of this study was to test this hypothesis using
a broad panel of immunohistochemical markers in infants
dying suddenly of causes that were either explained or
remained unexplained following post mortem investiga-
tions. Clarifying the nature of these cells is important
for our understanding of the biology of the infant
hippocampus and essential for the practice of diagnostic
neuropathology.
Materials and methods
This study was conducted with the approval of the local
research ethics committee (05/Q0508/96). Cases were
selected from the archive of Great Ormond Street Hospital
if they met the following conditions: after a full post
mortem examination, including ancillary investigations,
the cause of death was either explained or unexplained
sudden unexpected death in infancy (SUDI); formalin-
fixed, paraffin-embedded hippocampal tissue was avail-
able; and, prominent rod cells were present in the PML of
the hippocampus. In total 40 cases were included, 20
explained SUDI [eSUDI, aged 0–314 corrected days (post-
natal age minus the difference between term and gesta-
tional age at birth if preterm), mean age 55 days, 12
males] and 20 unexplained SUDI (uSUDI, aged 18–338
corrected days, mean 95 days, 11 males). The causes of
death in the eSUDI group are shown in Table 1. Based on
our observations during clinical practice, we predicted
that 20 cases in each group would be adequate to charac-
terize the immunophenotype of the rod cells.
An initial cohort of five cases (three eSUDI and two
uSUDI cases) was selected at random and from these,
5-μm-thick sections of hippocampus were cut and
immunostained, using an automated stainer (Bond-Max
Leica, Wetzlar, Germany) as per the manufacturer’s
instructions, with a panel of 16 antibodies: CD31
(pre-diluted, Leica PA0250), CD34 (pre-diluted, Leica
PA0212), CD45 (1:500, Dako M0701, Glostrup,
Denmark), CD68 (pre-diluted, Leica PA0273), CD133
(1:25, MACS 130-098-826, Bergisch Gladbach,
Germany), doublecortin (DCX, 1:1500, Abcam ab18723,
Cambridge, UK), epithelial membrane antigen (EMA, pre-
diluted, Leica PA0035), glial fibrillary acidic protein
(GFAP, 1:20 000, Dako 20334), human leucocyte
antigen-DR (HLA-DR, 1:3000, Dako M0775), Ki67 (pre-
diluted, Leica PA0118), microtubule-associated protein 2
(MAP2, Sigma-Aldrich M4403, St. Louis, MO, USA),
nestin (1:2000, Millipore AB5922, Darmstadt, Germany),
octamer-binding transcription factor 3/4 (Oct3/4, pre-
diluted, Leica PA0934), sex determining region Y-box 2
(SOX2, 1:500, Millipore AB5603), neuron-specific class
III beta-tubulin (TUJ1, 1:2500, Covance MMS-435P,
Greenfield, IN, USA) and vimentin (pre-diluted, Leica
SRL33). Appropriate positive controls for each antibody
were stained in parallel (Supplementary Figure S1). Nega-
tive controls, lacking primary antibody, showed no non-
specific staining. Sections of hippocampus from the
remaining 35 cases were all immunostained with CD68,
CD133, DCX, nestin and TUJ1. A section from each case
was stained with haematoxylin and eosin (H&E).
Staining was assessed blind to the cause of death. In
every case, one section per stain was assessed either quali-
tatively (nestin and TUJ1) or quantitatively (DCX). As the
development of the two limbs of the DG progresses at dif-
ferent rates [4] and the rod cells are not uniformly distrib-
uted, the immunoreactivity of rod cells in the PML of both
the superior and inferior limbs of the DG was assessed.
Images were taken at × 20 objective, using a Digital
Microimaging Device (DMD108, Leica), of the two areas
of the PML, where the rod cells were qualitatively assessed
to be densest, in both the superior and inferior limbs of the
Table 1. Causes of death in the eSUDI group
Infection, including CNS infection 5
Congenital, non-CNS abnormalities 4
Chronic respiratory disease 3
Hypoxic/ischaemic encephalopathy 3
Non-traumatic intracranial haemorrhage 2
Multi-organ failure 2
Complication of cardiac surgery 1
Total 20
CNS, central nervous system.
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DG for each stain (that is, four fields of view per section).
Immunoreactivity for nestin and TUJ1 was assessed quali-
tatively: the proportion of positive cells was estimated by a
neuropathologist, blind to the cause of death, in each of
the four fields of view per case. Staining for DCX was
assessed quantitatively: the total number of rod cells and
the number that were immunoreactive for DCX were
counted manually using ImageJ [10] in each of the four
fields per case. Statistical analyses were performed using
SPSS.
Results
The rod cells of the PML of the DG are
consistently negative for three sensitive
immunohistochemical markers of microglia
The rod cells in the initial cohort of five cases were uni-
formly negative for the microglial markers CD68, CD45
and HLA-DR (Figure 1). In the larger cohort of 40 cases,
all had rod cells present but only six cases of eSUDI and
one of uSUDI had significant numbers of infiltrating
CD68-positive microglia. However, even in cases where
there was a florid CD68-positive microglial response (e.g.
established hypoxic/ischaemic injury), a consistent popu-
lation of rod cells was present that were negative for CD68.
CD68 did not stain the rod cells of the PML in any of the
remaining cases.
Irrespective of the cause of death, many of the
rod cells of the PML of the DG are positive for
immunohistochemical markers of neural
progenitor cells
In all cases, rod cells were immunoreactive for
doublecortin, nestin and TUJ1 (Figure 2). The proportions
of cells that were stained by nestin and TUJ1 was assessed
qualitatively and found to be between 10% and 30% and
60% and 80% respectively. Quantitative assessment of
DCX expression showed that in the superior and inferior
limbs 13.2% [95% confidence interval (CI) 10.7–15.7%]
and 12.5% (95% CI 9.8–15.2%) of rod cells were positive
Figure 1. Sections from cases of eSUDI (A–E) and uSUDI (F–J). CD68-positive microglia were present in some cases (B and G), but the rod
cells (arrows) of the polymorphic layer of the dentate gyrus were negative for CD68 and the other microglial markers CD45 (C and H) and
HLA-DR (D and I). A CD45-positive circulating lymphocyte is seen within a vessel (C). The endothelial cells, but not the rod cells, expressed
CD34 (E and J). All images × 20 objective.
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Figure 2. Sections from cases of eSUDI (A–F) and uSUDI (G–L). The majority of the rod cells (arrows) were positive for TUJ1 (B, E, H and K).
Between 10% and 30% of the cells expressed DCX (A, D, G and J) and nestin (C, F, I and L). Images A–C, G–I × 20 objective; D–F, J–L × 63
objective.
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respectively. Occasional rod cells were positive for the pro-
liferation marker Ki67 (Supplementary Figure S2). The
rod cells were uniformly negative for the stem cell markers
CD133 and Oct3/4 (Supplementary Figure S2). In two of
five cases stained, cytoplasmic immunoreactivity to SOX2
was noted in rare rod cells but nuclear staining was not
present (Supplementary Figure S2).
Although, some endothelial cells were immunoreactive
for nestin, as has previously been reported [11], neither
DCX, nor TUJ1 stained the endothelial cells and the rod
cells were uniformly negative for the endothelial markers
CD31 and CD34 (Supplementary Figure S2). The rod cells
were negative for the intermediate filament vimentin,
the microtubule-binding protein MAP2, the ependymal
marker EMA and glial marker, GFAP (Supplementary
Figure S2). Expression of CD133, EMA and GFAP was
noted in ependymal cells only, as expected (data not
shown).
Rod cells of the PML are present in infants dying
from eSUDI and uSUDI beyond 9 months of
corrected age
As cases were selected on the basis that they contained
prominent clusters of rod cells in the PML, statistical
analysis of the relationship between the number of rod
cells and age or cause of death was not possible. However,
we did observe that prominent clusters of rod cells were
present beyond the age of 9 months, in four cases with
corrected ages of 299, 314, 334 and 338 days.
Discussion
We have described the identity of a population of neural
progenitors in the infant hippocampus that have been pre-
viously regarded as microglia. Several lines of evidence
support this conclusion. First, using a range of sensitive
markers of microglia, we have not found evidence of a
significant population of microglia in the PML of infants
dying of both explained and unexplained SUDI. This is in
contrast to the only other study that addressed the identity
of these cells [5]. The disparity between our findings and
those previously reported are likely to be due to the speci-
ficity of the different techniques employed. We used three
sensitive and relatively specific immunohistochemical
markers of microglia in a cohort of five cases and stained
the remaining 35 cases with one of these, CD68, which is
the marker most commonly used in diagnostic neuropa-
thology. In no case was a significant population of rod cells
stained by these markers. In a previous study, 18 cases
were stained with lectin histochemistry and the immuno-
histochemical marker HAM56 [5]. Histochemistry using
RCA-1 and the avidin–biotin peroxidase system has
been shown to detect microglia [12] but it also binds
endothelial cells [5,12,13]. Likewise, the HAM56 anti-
body reacts with microglia but also macrophages [5] and
endothelial cells [14,15]. Neither of these techniques
has been reported to detect neural progenitor cells. Of
note, the ultrastructural analysis conducted in the origi-
nal report did not demonstrate lysosomes [5], structures
which are typically present in microglia [16].
Second, using a range of immunohistochemical pro-
genitor cell markers, we have shown that the rod cells of
the PML of the DG in infants have the phenotype of neural
progenitor cells. The markers we used are differentiation
dependent, identifying pluripotent cells (Oct3/4 [17],
CD133 [18] and SOX2 [19]), neuroepithelial precursor
cells (nestin [20]), immature neurones (TUJ1 [21]) and
migrating and differentiating neurones (MAP2 and DCX
[22]). Some of the earliest progenitors are also immuno-
reactive for GFAP [23]. The majority of the rod cells in the
PML are immunoreactive for TUJ1, with a minority stain-
ing for the earlier markers nestin and DCX [24], suggest-
ing that they are a population of committed neural
progenitor cells with modest variability in differentiation.
The presence of occasional Ki67-positive cells, despite the
tissue being post mortem, confirms that the cells are prolif-
erating. No method capable of detecting neural progenitor
cells was used in the previous report [5]. Postnatal
neurogenesis in the DG is well described, in both experi-
mental animals [25–27] and humans [28] and is impli-
cated in the formation of new memories [29]. The
previous reports [4,5] and our observations support the
hypothesis that the population of cells we have character-
ized is transient, declining in number towards the end of
the first year of life. How these developmental progenitors
relate to those seen later in life is an interesting question.
The present data challenge two conclusions which have
been drawn on the basis of the previous report of the
distribution and lineage of the rod cells of the PML [5].
First, the observation that these cells were more numerous
in cases of SIDS and in infants dying of a range of chronic
hypoxic or hypotensive states [5], has been interpreted as
evidence of hypoxic/ischaemic brain injury in SIDS [6,7].
We have shown that a population of rod cells in the PML is
a normal finding, being present in infants dying of both
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eSUDI and uSUDI, and that these cells are not microglia
but neural progenitor cells. Therefore, for diagnostic pur-
poses, simply commenting on the presence of these cells as
evidence of a pathological process, without some form
of quantification, is inadequate. If there are increased
numbers of these cells in SIDS or hypoxic/ischaemic
injury, this may be due to enhanced neurogenesis, either
as part of an underlying pathological process or as a reac-
tive phenomenon. While the aims of our study did not
include correlating the number of rod cells with the cause
of death, given that abnormalities of the neuronal popu-
lations of the hippocampus have been associated with
sudden death in childhood [2] and epilepsy [1], it is plau-
sible that this population of neural progenitor cells may
contribute to specific disease states, including SIDS. Alter-
natively, given the previous report of increased numbers of
rod cells in infants dying of chronic hypoxic or hypoten-
sive conditions [5], they may proliferate in response to
various stresses, including hypoxia.
Second, the initial report that rod cells were not observed
in infants surviving less than 4 days after brain injury
[5] has been interpreted to indicate that a period of survival
of 4 days or more is required after an insult for a micro-
glial response to become apparent neuropathologically
[8]. Determining the timing of a brain injury from
neuropathological changes is a frequent and import-
ant issue in diagnostic practice. As the predominant
immunophenotype of the rod cells in the PML is not
microglial, we argue against using the presence of these
cells as an indicator of the timing of neuropathological
changes. Rather, we suggest that evidence from reports
specifically addressing this question should be used
[30–32].
In summary, we have shown that a population of cells
in the infant hippocampus are not, as previously reported,
microglia but neural progenitor cells. This finding is an
important step forward in our understanding of postnatal
neurogenesis in the hippocampus and has critical impli-
cations for the practice of diagnostic neuropathology. The
fascinating possibility of a relationship between these cells
and particular causes of death needs further work, but
may provide a clue to the pathogenesis of diseases, such
as SIDS.
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Additional Supporting Information may be found in the
online version of this article at the publisher’s web-site:
Figure S1. Positive controls were stained in parallel
with the cases and each showed the expected pattern of
immunoreactivity. CD31 (brain, A), CD34 (brain, B),
CD45 (tonsil, C), CD68 (brain, D), CD133 (pancreas, E),
DCX (brain, F), EMA (brain, G), GFAP (brain, H), HLA-DR
(tonsil, I), Ki67 (small intestine, J), MAP2 (brain, K),
nestin (brain, L), Oct3/4 (germinoma, M), SOX2 (focal
cortical dysplasia, N), TUJ1 (small intestine, O), vimentin
(brain, P). All images × 20 objective.
Figure S2. The rod cells (arrows) were negative for the
immunostains CD31 (A), CD133 (B), EMA (C), GFAP (D),
MAP2 (F), Oct3/4 (G), SOX2 (H) and vimentin (I). An
occasional rod cell was positive for Ki67 (white arrow, E),
an epitope that is particularly prone to post mortem degra-
dation. All images × 20 objective.
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